News | RIVM

Safety of materials and products already starts at the design phase

The Ministry of Infrastructure and Water Management aims to ensure that all new materials and technological developments are safe in 2050.

Onderzoeker met veiligheidsbril bekijkt preparaat

Can you solve a medical mystery?

During World Antibiotic Awareness Week 2019, RIVM has set up an escape room in one of busiest shopping malls in the Netherlands.

Possible health risks due to exposure to chromium-6 at tROM project Tilburg

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Health effects due to titanium nanoparticles in food and toothpaste cannot be excluded

Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.

Bacteria slightly more often resistant to last resort antibiotics

Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.

Tool for risk assessment of nanomaterials in cosmetics

Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.

Nanotechnology increasingly used in medical devices

The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.

European Antibiotic Awareness Day: the fight against antibiotics resistance

Wednesday, 18 November is European Antibiotic Awareness Day. On this day, attention throughout Europe is requested for the responsible use of antibiotics in people and animals.

CAESAR annual report 2014

The World Health Organization (WHO) published its first CAESAR annual report 2014.

Antibiotic resistance is stable, however, more resistant bacteria are expected

Over recent years, antibiotic resistance to most agents has remained stable in the Netherlands, and the use of antibiotics has slightly decreased.